Mounjaro Is Now Approved to Lower the Risk of Heart Events

The new indication for Eli Lilly's drug is for people with Type 2 diabetes.

Več na: https://time.com/article/2026/08/28/eli-lilly-drug-mounjaro-approved-to-lower-heart-events-risk/

Vse znamke, logotipi in slike so zaščitene in so last lastnikov oz. družb. Vse pravice pridržane. © 1998-2023 Aguatera d.o.o.